Expression levels of two of the examined genes – GRHL1 and GRHL3 – were significantly reduced in basal cell carcinoma (BCC) samples as well as in squamous cell carcinoma (SCC) samples, in comparison with the control healthy tissue from the same patient. This evidence concerns the gene GRHL3 and skin basal cell carcinoma.